• Impacto Orçamentário Do Everolimo, Sirolimo E Tacrolimo Para Imunossupressão Em Transplantados Cardíacos No Sistema Público De Saúde Do Brasil

    Nov 1, 2015, 00:00

  • Influence of Some Factors on The Morphological Structure of Spermatozoa In Straight Intestine During Forensic - Medical Examination of Sodomy

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Incobotulinumtoxin-A With Flexible Treatment Intervals Compared to Onabotulinumtoxin-A In The Management of Blepharospasm And Cervical Dystonia

    Nov 1, 2015, 00:00

  • The Societal and Economic Impact of Cervical Cancer in Brazil

    Nov 1, 2015, 00:00

  • Prescription Patterns Of Drugs For Attention-Deficit/Hyperactivity Disorders In Japanese Children And Adolescents

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Intravitreal Aflibercept Compared with Ranibizumab-Prn in Patients with wet Age-Related Macular Degeneration (Wamd)

    Nov 1, 2015, 00:00

  • Economic Evaluation Of A Pharmacogenomic Test For Statin-Induced Myopathy In Cardiovascular High-Risk Patients Initiating A Statin

    Nov 1, 2015, 00:00

  • Productivity Loss Due to Low Back Pain- Results from Swedish Registers

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Plaque Psoriasis In The Italian Setting

    Nov 1, 2015, 00:00

  • Review Of Comorbidity Measures To Predict Economic Outcomes In Real-Life Database Studies

    Nov 1, 2015, 00:00

  • An Analysis of Diabetic Medicine Utilization In Turkey

    Nov 1, 2015, 00:00

  • Analysis of Preeclampsia Prevention in Real Practice and the Need to Improve Information Support of Doctors in Ukraine

    Nov 1, 2015, 00:00

  • Analysis Of Costs For Diagnosis And Differential Diagnosis Of Patients With Possible Temporomandibular Disorders In Ukrane

    Nov 1, 2015, 00:00

  • Romania’s New HTA System- What Progress have Innovative Drugs Made under the Points-Based System So Far?

    Nov 1, 2015, 00:00

  • Cost-Utility of Omalizumab Compared With Standard of Care for The Treatment of Chronic Spontaneous Urticaria (Csu)

    Nov 1, 2015, 00:00

  • Early Benefit Assessment And Uptake Of Pharmaceutical Innovations – Experiences From Germany 2011 To 2014

    Nov 1, 2015, 00:00

  • Effect of Educational Intervention on Osteoporosis Knowledge Among University Female Students in Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Weight Loss Treatment Patterns in Mexico

    Nov 1, 2015, 00:00

  • Efficacy of The Mica Antibody for Transplant Patients

    Nov 1, 2015, 00:00

  • Interpreting Results from Bayesian Network Meta-Analyses (Nma)- A Guide for Non-Statisticians

    Nov 1, 2015, 00:00

  • Measurement Of Hope In Patients With Cancer

    Nov 1, 2015, 00:00

  • The Diabetes Telephone Study- Design and Challenges of a Pragmatic Cluster Randomized Trial to Improve Diabetic Peripheral Neuropathy Treatment

    Nov 1, 2015, 00:00

  • The Cost Of Nutrition Alternatives For Premature Infants In The Neonatal Intensive Care Unit In Russia

    Nov 1, 2015, 00:00

  • Benefit-Risk of Vka for Atrial Fibrillation Before Doac- a Cohort Study in a Claims and Hospitalization Database

    Nov 1, 2015, 00:00

  • A Systematic Review Of Markov Models Evaluating Multi-Component Disease Management Programs

    Nov 1, 2015, 00:00

  • Utility Values for Health Technology Assessment- Learning Lessons from Economic Models of Pharmaceuticals Submitted to the French National Authority for Health (Has)

    Nov 1, 2015, 00:00

  • Costs Associated With Patients Diagnosed With Relapsing Remitting Multiple Sclerosis Taking Once Daily Fingolimod Capsules In The United States

    Nov 1, 2015, 00:00

  • Character of Toxic Damage of Liver In Influences of Substances of Mediator to Fetal Cells on Hepatocytes In Acute Liver Failure

    Nov 1, 2015, 00:00

  • Costs of Absenteeism In Ankylosing Spondylitis Based on Real-Life Data From Poland’s Social Insurance Institution Database In 2013

    Nov 1, 2015, 00:00

  • Costo De Tuberculosis En Los Establecimientos De Salud Del Perú

    Nov 1, 2015, 00:00

  • Differences Between The Efficacy of Biosimilars and Originators - Analysis and Implications for The Cost-Effectiveness-Analysis From A Payers Perspective

    Nov 1, 2015, 00:00

  • Access To The Procedure Care of Colorectal Cancer In Brazilian Public Health System- Use Of Diagnosis Resources In São Paulo State

    Nov 1, 2015, 00:00

  • Targeted Combination Regimes In Oncology Challenges for Pricing and Reimbursment In Switzerland- Analysis of The Implication and Operational Requirement For Implementation of An Indication Code

    Nov 1, 2015, 00:00

  • Adherence of hiv patients switching to emtricitabina+tenofovir disoproxil+rilpivirin. Real world evidence from italian administrative databases

    Nov 1, 2015, 00:00

  • Evolution of Treatment Paradigms In Metastatic Castrate-Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Availability Of Drugs Recommended By Global Initiative For Chronic Obstructive Lung Disease (Gold) For Ukrainian Patients With Copd

    Nov 1, 2015, 00:00

  • Pro Self-Assessment and Patient Retention in Major Depression Studies- Efficiency of a Direct-To-Patient Contact Approach

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Capsule Endoscopy Using For Diagnosing Small Bowel Crohn’s Disease

    Nov 1, 2015, 00:00

  • International Comparison of Internet Information Source in Breast Cancer

    Nov 1, 2015, 00:00

  • National Study to Assess The Costs of Patients With High Myopia With and Without Choroidal Neovascularisation

    Nov 1, 2015, 00:00

  • Development Of A Patient-Reported Outcome (Pro) Assessment Of Core Non-Small Cell Lung Cancer (Nsclc) Symptoms

    Nov 1, 2015, 00:00

  • Choice of Antithrombotic Drug in non-Valvular Atrial Fibrillation Patients in Real-World Practice

    Nov 1, 2015, 00:00

  • Review and Comparison of Eq-5d-3l Valuation Studies

    Nov 1, 2015, 00:00

  • Quality of Life Issues Important to Patients with Haematological Malignancies

    Nov 1, 2015, 00:00

  • Contraception Patterns In Fran A Real-World Database Analysis

    Nov 1, 2015, 00:00

  • Fixed Combination Netupitant And Palonosetron Is A Cost-Effective Intervention For The Prevention Of Chemotherapy-Induced Nausea And Vomiting In The Uk

    Nov 1, 2015, 00:00

  • Building Intentions with The Theory of Planned Behaviour- A Qualitative Assessment of Salient Beliefs About Pharmacy Value Added Services in Malaysia

    Nov 1, 2015, 00:00

  • Critical Analysis of Pricing and Reimbursement Process on The Basis of New Indroduced Pharmacoeconomic Guidelines In Bulgaria

    Nov 1, 2015, 00:00

  • Comparative Analysis of The Reimbursement Landscape of Orphan Drugs on An International Level

    Nov 1, 2015, 00:00

  • Health Technological Supports to Detect Medication Errors- The Saniarp Case-Study

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Implementing Tenders Between The Branded Infliximab And Its Biosimilars In The Public Hospitals of Paris

    Nov 1, 2015, 00:00

  • Rapid Increase of Health Litigation As A Means of Market Access For Innovative Medicines In Colombia And The Potential Role Of Health Technology Assessment

    Nov 1, 2015, 00:00

  • Association between Weight Change, Diabetes-Related Healthcare Costs, and HbA1c among Patients with Type 2 Diabetes

    Nov 1, 2015, 00:00

  • Economic Evaluation of Chondroitin Sulfate and Non-Steroidal Antiinflammatory Drugs for The Treatment of Osteoarthritis

    Nov 1, 2015, 00:00

  • Survey of the Hungarian Physiotherapists’ Migration and Career Changing Behaviour

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Zoledronic Acid Versus Alendronic Acid In The Treatment of Osteoporosis In Postmenopausal Egyptian Patients- Decision Analysis

    Nov 1, 2015, 00:00

  • Patient Reported Outcome in Health Services Research- A Prospective Study of Orthopedic Surgery in Routine Care in Switzerland

    Nov 1, 2015, 00:00

  • Number of Osteoporosis Patients with Pathological Fractures By Gender in Outpatient Care in the Light of Physiotherapy Care in Hungary

    Nov 1, 2015, 00:00

  • Real World Data- Biologic Treatment for Naive Patient in the Lazio Region

    Nov 1, 2015, 00:00

  • A Streamlined Approach to Ethics Review in Brazil

    Nov 1, 2015, 00:00

  • A Pitcure of Private Health Insurance Policyholders in Italy

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of Phased Radiofrequency (Rf) Catheter Ablation System In The Treatment Of Atrial Fibrillation (Af) In Turkey

    Nov 1, 2015, 00:00

  • Assessment of Direct Cost for Treatment of Influenza and Ari for Outpatient In Ukraine

    Nov 1, 2015, 00:00

  • The Devil Is Not So Black As He Is Painted – The Future of Immunization In Poland

    Nov 1, 2015, 00:00

  • Quality Of Life In Patients With Kidney Cancer In Slovakia

    Nov 1, 2015, 00:00

  • Quantifying The Impact of Treatment on The Public Health Burden of Adpkd- A Uk Case Study Using The Adpkd Outcomes Model

    Nov 1, 2015, 00:00

  • Characteristics of Patients with Relapsing Remitting Multiple Sclerosis Taking once Daily Teriflunomide Tablets in the United States

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Of Bariatric Surgery In Germany

    Nov 1, 2015, 00:00

  • Orphan Drugs Assessment in Germany- A Comparison with Other International HTA Agencies

    Nov 1, 2015, 00:00

  • Burden of Disease of Ovarian Cancer in Spain. Ovarcost Study

    Nov 1, 2015, 00:00

  • Cognitive Debriefing And Usability Assessment Of The Eortc Qlq-C30 And Qlq-Br23 As Presented On Tablet And Handheld Devices

    Nov 1, 2015, 00:00

  • Characteristics of Patients With Relapsing Remitting Multiple Sclerosis Taking Disease Modifying Agents

    Nov 1, 2015, 00:00

  • Building a Bridge Between Clinical Evidence Research and Patient Preference Research

    Nov 1, 2015, 00:00

  • Intra- And Extra-Organizational Factors Affecting Community Pharmacy Performance

    Nov 1, 2015, 00:00

  • What Is Ce Marking? How Technologies Are Classified, And How To Navigate The System

    Nov 1, 2015, 00:00

  • Healthcare Costs In Psoriatic Arthritis Patients Newly Initiated on Apremilast or Biologic Therapies

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Central Retinal Vein Occlusion (Crvo) In Turkey- An Expert Panel Approach For Estimation of Costs

    Nov 1, 2015, 00:00

  • Drug Pricing Information Management- Development Of A Web Based E-Pricing System

    Nov 1, 2015, 00:00

  • Bayesian Econometric Modelling Of Observational Data For Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00

  • Leptospirosis; A Zoonotic, Morbid and Fatal Disease- A Record Viewing Study

    Nov 1, 2015, 00:00

  • Cost-Utility of Fingolimod Compared With Dimethyl Fumarate (Dmf) In Highly Active Relapsing Remitting Multiple Sclerosis (Rrms) In England- Comparison of A Markov and Discrete Event Simulation Model

    Nov 1, 2015, 00:00

  • A Cost-Effective Enhanced Retrospective Observational Study Methodology to Capture Economic Burden Evidence in a Rare Disease Using Non-Tuberculous Mycobacteria Infection as a Model

    Nov 1, 2015, 00:00

  • The Economic Consequences Of The Use Of Antibiotics In Belgium

    Nov 1, 2015, 00:00

  • Individual and Societal Burden of Non-Adherence to Antidepressants in Brazil

    Nov 1, 2015, 00:00

  • Review Of The Current Status Of Ras Mutation Testing In Patients With Metastatic Colorectal Cancer (Mcrc)- Flash-Ras Study

    Nov 1, 2015, 00:00

  • Risk of Fracture in Type 2 Diabetes Mellitus Patients- Meta-Analysis of Observational Studies

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Evaluation Comparing Biosimilar Bemfola to Gonal-F for the Treatment of Infertility in an Italian Contest

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation Of The Use Of Trastuzumab For Subcutaneous Administration Compared To Intravenous Dosage Form In The Treatment Of Breast Cancer

    Nov 1, 2015, 00:00

  • Experts Consensus on The Future of Rare Diseases Care and Orphan Drugs Access In Spain- A Delphi Study

    Nov 1, 2015, 00:00

  • Cost of Paediatric Vaccine Administration in the United Kingdom (UK)- a Time and Motion (TM) Study

    Nov 1, 2015, 00:00

  • Clinical And Economic Analysis Of Effectiveness Of Fondaparinux Sodium In The Treatment Of Acute Coronary Syndrome

    Nov 1, 2015, 00:00

  • Estimation of The Relative Efficacy of Licensed Regimens for Genotype-1 Hcv Infection Using A Mixed Treatment Comparison

    Nov 1, 2015, 00:00

  • Management Of Sore Throat In Community Pharmacy In Fran A National Observational Study

    Nov 1, 2015, 00:00

  • The 3-Arm Strategy for Readmission Prevention- Automated Predictive Modeling, Readmission Prevention Intervention, and Monitoring

    Nov 1, 2015, 00:00

  • Atrial Fibrillation And Anti-Coagulation Service Run By A Clinical Nurse Specialist

    Nov 1, 2015, 00:00

  • How Has The Smc Patient And Clinician Engagement (Pace) Process Been Used In Assessments Of End-Of-Life Medicines And Medicines To Treat Very Rare Conditions?

    Nov 1, 2015, 00:00

  • The Cost-Of-Disease (Cod) In Diabetic Macular Edema (Dme) In Turkey- An Expert Panel Approach for Estimation of Costs

    Nov 1, 2015, 00:00

  • Identification Of Items For A Standardised Resource-Use Measure- Review Of Current Instruments

    Nov 1, 2015, 00:00

  • Multi European Country Cost Consequence Comparison Of Floseal Matrix And Surgiflo Thrombin In Major And Severe Spine Surgeries

    Nov 1, 2015, 00:00

  • Evaluation Analysis of Smoking Population in Ulaanbaatar

    Nov 1, 2015, 00:00

  • Similarities and Differences In Orphan Drug Reimbursement In 16 European Countries

    Nov 1, 2015, 00:00

  • Bone Pain And Bone Targeting Agent (Bta) Treatment Patterns In Patients With Bone Metastases (Bms) From Breast Cancer (Bc) In Real World Setting In Europe

    Nov 1, 2015, 00:00

  • A Review of Patient Registries in Heart Failure Across European Union-5 Countries

    Nov 1, 2015, 00:00

  • Cost of Illness (Out of Pocket Costs Paid By Patient) for T.B in Quetta City, Pakistan

    Nov 1, 2015, 00:00

  • Indirect Treatment Comparison (Itc) To Demonstrate The Utility Of Oncolitbank- An Oncology Literature Registry

    Nov 1, 2015, 00:00

  • Compliance With Allopurinol Among Hypertensive Patients With Gout Diagnosis and The Relationship to Onset of End-Stage Renal Disease

    Nov 1, 2015, 00:00

  • Cost Analysis of Voriconazole Versus Liposomal Amphotericin B for Primary Therapy of Invasive Aspergillosis among High-Risk Hematologic Cancer Patients in Brazil

    Nov 1, 2015, 00:00

  • Exenatide Once Weekly Plus Metformin for the Treatment of Type 2 Diabetes Mellitus- A Network Meta-Analysis of Randomised Controlled Trials

    Nov 1, 2015, 00:00

  • Management of Statin Intolerance (Si) in Patients at High Risk for Cardiovascular (Cv) Events- Results of a Canadian Study

    Nov 1, 2015, 00:00

  • Economic Analysis of Outpatient Parenteral Antimicrobial Therapy (Opat)- A Systematic Review

    Nov 1, 2015, 00:00

  • Improved Survival With Ipilimumab In Patients With Advanced Melanoma In Real-World Clinical Practi First Results Of The Dutch Melanoma Treatment Registry

    Nov 1, 2015, 00:00

  • Campañas de Medicamentos; Instrumento Publicitario Que Atenta Contra Los Genéricos y el Acceso a Medicamentos

    Nov 1, 2015, 00:00

  • Patterns Of Medication Use In Chronic Kidney Disease Stage 5d- Emphasis On Medications For The Management Of Ckd-Mbd

    Nov 1, 2015, 00:00

  • Assessment of Hiv-Related Quality of Life in a Representative Sample Of French Patients using Multivariate Multi-Block Statistical Models

    Nov 1, 2015, 00:00

  • Closing The Financial Gap of Antiretroviral and Hiv Supplies For Sustainability of Hiv National Response In The Dominican Republic

    Nov 1, 2015, 00:00

  • Development of Ms Budget Manager- A Practical Tool to Assist Alternative Stakeholders At Multiple Decision Levels In The Forecast And Financial Management For Multiple Sclerosis (Ms)

    Nov 1, 2015, 00:00

  • An Update on Healthcare Resource Use and Economic Burden In Alzheimer’s Disease In The United States (Us) From A Medicare Sample Analysis

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a In Italian Relapsing Remitting Multiple Sclerosis Management

    Nov 1, 2015, 00:00

  • Revision Sistemática De Estudios De Costo Efectividad De Intervenciones Sanitarias Para La Cesacion Del Hábito Tabáquico

    Nov 1, 2015, 00:00

  • Challenges and Benefits of Conducting Value of Information Analysis from the Perspective of Industry- A Simulation Study

    Nov 1, 2015, 00:00

  • An Epidemiological Evaluation Of The Incidence Of Deep Venous Thrombosis And Pulmonary Embolism In Patients With Hip Or Knee Replacement Surgery And Of Its Impact On The Average Length Of Stay And Hospitalization Cost

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Evaluation of the Introduction of Routine Varicella Vaccination in Children in the United Kingdom

    Nov 1, 2015, 00:00

  • Trends in Non-Submissions in the UK

    Nov 1, 2015, 00:00

  • Skin Whitening Multiple Emulsions Loaded with Green Tea and Lotus Extracts- an Efficacy Study

    Nov 1, 2015, 00:00

  • Therapy Of Depression In Cancer And Non-Cancer Patients In German Neuropsychiatric Practices

    Nov 1, 2015, 00:00

  • An Epidemiological Evaluation Of The Impact Of Percutaneous Coronary Interventions On The Hospitalization Cost, Length Of Stay And Mortality Of Patients Hospitalized With Acute Coronary Syndromes

    Nov 1, 2015, 00:00

  • Resource Use And Exacerbations Of Chronic Obstructive Pulmonary Disease (Copd) By Gold Categories

    Nov 1, 2015, 00:00

  • Economic Sanctions And Market Access for Pharmaceuticals- Case Studies With Russia, Cuba And Iran

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life In Patients With Adrenal Insufficiency Receiving Plenadren Compared With Immediate-Release Hydrocortisone

    Nov 1, 2015, 00:00

  • Relationship between Spending on Diabetes Drugs and Occurrence of Risks Associated with Type 2 Diabetes in English General Practices

    Nov 1, 2015, 00:00

  • Health And Economic Outcomes Related to Delay Between Medical Indication and Treatment With Ranibizumab In Age-Related Macular Degeneration In Greece

    Nov 1, 2015, 00:00

  • Characteristics and Outcomes of Patients with Dengue Viral Infection During The Hospitalization At Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • A Pragmatic Approach to Data Source Selection for use In Real-World Evidence (Rwe) Generation

    Nov 1, 2015, 00:00

  • Risk Factors for Coronary Artery Disease In Patients With Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • Does The Atu Process Have An Impact On Time To Market Launch?

    Nov 1, 2015, 00:00

  • Exploring Variation in Cost-Effectiveness Estimates in Studies that Evaluate Adult Pneumococcal Vaccination in Latin America

    Nov 1, 2015, 00:00

  • Patient Benefits And Cost Savings Predicted For Mineralocorticoid-Receptor Antagonist Treatment Of Early And Advanced Diabetic Kidney Disease

    Nov 1, 2015, 00:00

  • Immunisation in Latin America- Factors Preventing Uptake of Cost-Effective Vaccines

    Nov 1, 2015, 00:00

  • Incorporation Of Evidence Based Medicine Into The European Observatory On Health Systems And Policies Document Describing The Health Systems Of Countries Not Belonging To The European Union

    Nov 1, 2015, 00:00

  • Diabetes Duration and Severity and Labour Market Outcomes In Mexico

    Nov 1, 2015, 00:00

  • Treatment Satisfaction With Disease Modifying Therapies In Multiple Sclerosis- A Systematic Review of Studies Using The Treatment Satisfaction Questionnaire For Medication (Tsqm)

    Nov 1, 2015, 00:00

  • Systematic Review Of Cost Effectiveness Of Gefitinib In The Treatment Of Non-Small Cell Lung Cancer In China

    Nov 1, 2015, 00:00

  • Economic Considerations In Clinical Guidelines - Are Patient Perspectives Considered?

    Nov 1, 2015, 00:00

  • Development of A Screening Tool to Support Identification of Patients With Secondary Progressive Multiple Sclerosis (Spms)

    Nov 1, 2015, 00:00

  • Selecting Evidence-Based Preventive Treatment Thresholds By Optimizing Preferred Outcomes

    Nov 1, 2015, 00:00

  • Public Health Outcomes of Paediatric Influenza Vaccination With An Intranasal Tetravalent Live Attenuated Vaccine In Belgium Using A Dynamic Transmission Model

    Nov 1, 2015, 00:00

  • The Cost–Effectiveness Of Regorafenib In The Treatment Of Patients With Metastatic Colorectal Cancer (Mcrc) Who Have Progressed After Standard Therapies In Turkey

    Nov 1, 2015, 00:00

  • Comparative Effectiveness of Ticagrelor Vs. Prasugrel in Patients with Acute Coronary Syndrome

    Nov 1, 2015, 00:00

  • The Economics of the Treatment and Follow-Up of Patients with Glioblastoma

    Nov 1, 2015, 00:00

  • Statin Use and Risk of New-Onset Type 2 Diabetes Mellitus and Cardiovascular Disease- a Nationwide Population-Based Observational Study Using National Claim Data

    Nov 1, 2015, 00:00

  • Economic Burden of Pneumococcal Infections In Children Under Five Years Old

    Nov 1, 2015, 00:00

  • Health Economic Programming Using Royston-Parmar “Hazard Rate” Models- Providing Flexibility and Speed for Event Modelling In Cohort and Des Models

    Nov 1, 2015, 00:00

  • Additional Cost of Vte In Patients with Cancer- an Approach Based Databases

    Nov 1, 2015, 00:00

  • Cost-Effectivness Analysis of Shizophrenia Treatment With Haloperidol , Olanzapine And Risperidone In Bosnia and Hercegovina ,Republic of Srpska By Application of The Markov Model

    Nov 1, 2015, 00:00

  • Prescription Patterns of Antidiabetic Treatment in the Elderly. Results from Southern Italy

    Nov 1, 2015, 00:00

  • Cart Analysis As A Tool To Determine Optimal Treatment Intensification Time In Diabetes

    Nov 1, 2015, 00:00

  • The Challenges in Evaluating the Cost-Effectiveness of Complex Interventions

    Nov 1, 2015, 00:00

  • Total Annual Cost Associated with Best Supportive Care of Patients with Unresectable Advanced Non-Small-Cell Lung Cancer Under Real-World-Conditions in Relation to Results of International Studies

    Nov 1, 2015, 00:00

  • Introducing Orange- An International Price Reference Tool

    Nov 1, 2015, 00:00

  • Off-Label Use of Intravenous Immunoglogulins (IVIGS)- Funding Mechanisms in France, Germany, Italy, Spain and the United Kingdom (EU5)

    Nov 1, 2015, 00:00

  • Health Technology Assessment In Chronic Hepatitis C- Assessment of Decision Landscape And Manufacturer Inputs In Six Agencies

    Nov 1, 2015, 00:00

  • Burden of Heart Failure In Latin America- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • A Study on Cytogenetic Analyses and Mecp2 Mutation With Dopamine And Serotonin In Rett Syndrome (Rtt)

    Nov 1, 2015, 00:00

  • Clinical and Economic Burden of Prostate Cancer

    Nov 1, 2015, 00:00

  • Evaluation of Psoriasis Patients’ Attitude to Risk- Benefit And Therapeutic Tradeoffs In Their Choice of Treatments

    Nov 1, 2015, 00:00

  • The Challenges of Carrying out an Indirect Comparison with Single-Arm Studies

    Nov 1, 2015, 00:00

  • Analysis Of Primary And Secondary Apr-Drg Codes Of An Ischemic Stroke Admission

    Nov 1, 2015, 00:00

  • Investigation of the Living and its Impact to the Pregnants

    Nov 1, 2015, 00:00

  • Prediction Of Future Health Insurance Expenditures In Hungary According To Population Forecast Scenarios

    Nov 1, 2015, 00:00

  • Are the Irish Slower than they Think? A Systematic Analysis of all Recent Ncpe Appraisals

    Nov 1, 2015, 00:00

  • Translatability Assessment and Linguistic Validation of The Patient-Reported Outcome Instrument for Irritable Bowel Syndrome With Diarrhea (Ibs-D Pro)

    Nov 1, 2015, 00:00

  • Improving Patient Quality of Life By Verifying And Enhancing Quality of Orthopaedic And Prosthetic Medical Devices

    Nov 1, 2015, 00:00

  • Envolvimento do Público no Processo de Incorporação de Tecnologias no Sus

    Nov 1, 2015, 00:00

  • The Influence Of The Revision Of The Medical Fee Schedule On National Hospital Organisation Hospitals In Japan

    Nov 1, 2015, 00:00

  • Treatment Strategies, Health Care Resource use and Costs of Aggressive Histological types of non-Hodgkin Lymphomas in the Slovak Republic. Results from the Cross-Sectional Survey in the Haematology-Oncological Centers

    Nov 1, 2015, 00:00

  • Economic Assessment of Eribulin Against Treatment of Physician’s Choice (Tpc) in Taiwan

    Nov 1, 2015, 00:00

  • Qualitative Interviews To Provide In-Depth Understanding Of The Impact Of Non-Small Cell Lung Cancer (Nsclc) And Its Treatment On Of The Lives Of Patients And Their Families/Caregivers

    Nov 1, 2015, 00:00

  • Efficacy And Safety Profile Of Combined Targeted Therapy Against Egfr And Vegf In Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer- A Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00

  • G-Ba Does not Adjust Evidence Requirements in Early Benefit Assessment in Cases of Pre-Defined, Efficacy-Based Cross-Over Decisions in Oncology Trials

    Nov 1, 2015, 00:00

  • Avaliação De Tecnologias No Tratamento Da Depressão Maior- Overview Sobre A Eficácia E Segurança Da Duloxetina, Venlafaxina E Trazodona Comparados À Fluoxetina

    Nov 1, 2015, 00:00

  • Trends In End-Of-Life Appraisals And Recommendations By Nice For Oncology Therapies

    Nov 1, 2015, 00:00

  • Opioid Addiction Treatment in the eu5- Market Access Levers for Emerging Brands Entering a Generic Market

    Nov 1, 2015, 00:00

  • Therapeutic Reference Pricing System In Slovenia From The Patients’ Perspective

    Nov 1, 2015, 00:00

  • Overview of Generics Policies and Penetration in Japan

    Nov 1, 2015, 00:00

  • Comparative Tolerability of New Antipsychotic Drugs in Schizophrenia- A Systematic Review and Meta-Analysis

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Gefitinib as the First Line Treatment in Patients With Positive Egfr Mutation In Metastatic or Locally Advanced non-Small Cell

    Nov 1, 2015, 00:00

  • Ten Years of The International Pompe Survey- Patient Reported Outcomes As A Reliable Tool for Studying Treated and Untreated Children and Adults With Non-Classic Pompe Disease

    Nov 1, 2015, 00:00

  • Higher Accuracy Of Blood Glucose Monitoring Systems In Type 2 Insulin Treated Diabetic Patients In Spain- Clinical And Economic Impact

    Nov 1, 2015, 00:00

  • Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the Treatment of Chronic Genotype 1 Hepatitis C in Mexico

    Nov 1, 2015, 00:00

  • Economic Analysis Of Evarrest® Sealant Matrix Compared With Standard Of Care In Severe Soft Tissue Surgical Bleeding- A German Hospital Perspective

    Nov 1, 2015, 00:00

  • Clinical Multi-Criteria Decision Assessment (Cmda)- A Proposal for Applying Mcda to Compare Treatments in a Simultaneous, Transparent and Overall Way

    Nov 1, 2015, 00:00

  • Indirect Comparison of Onabotulinum Vs. Oral Triptans for The Phrophylaxis Treatment of Chronic Migraine

    Nov 1, 2015, 00:00

  • A Discrete Choice Experiment For Engaging Patients In Reimbursement Decision Making- Patient Preferences On Adjuvant Chemotherapy In Breast Cancer

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Adjunctive Anti-Epileptic Drug Trials In Patients With Primary Generalized Tonic-Clonic Seizures Illustrates Changes in Standard of Care Over 12-20 Years

    Nov 1, 2015, 00:00

  • Economic Burden in Studies Published in 2014- What Type of Mental Health Disorders and Outcomes Have Been Most Commonly Assessed?

    Nov 1, 2015, 00:00

  • Patient-Reported Frequency and Burden of Hypoglycaemia for Insulin-Treated Diabetes Patients In 5 Cities of China- A Cross-Section Study

    Nov 1, 2015, 00:00

  • Medical Devices – Brest Forms. Cost And Quantity Characteristics Of Medical Devices In Slovakia 2009 – 2013

    Nov 1, 2015, 00:00

  • Purpose, Belief And Rate of Disclosure of Cam Use Among Diabetic Patients In Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Eroltinib Plus Gemcitabine Compared With Gemcitabine Monotherapy In Patients With Pancreatic Cancer- A Real-World Analysis Of Korean Nationa-Wide Database

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Fingolimod Versus Dimethyl Fumarate As A Second-Line Disease Modifying Treatment In Patients With Highly Active Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Costo - efectividad de la combinacion de glicopirronio/indacaterol vs. Salmeterol/ fluticasona (combinacion de dosis fija – cdf) en el manejo de los pacientes con enfermedad pulmonar obstructiva cronica (epoc) en colombia (sur américa)

    Nov 1, 2015, 00:00

  • Medical Cost Associated with Treatment and Follow-Up of Pantients with Head and Neck Cancer

    Nov 1, 2015, 00:00

  • Bayesian Network Meta-Analysis To Assess Relative Efficacy Of Ibrutinib Versus Idelalisib+Ofatumumab And Physician’s Choice In Relapsed/Refractory Cll Patients

    Nov 1, 2015, 00:00

  • Recommendations and Reimbursement Status of Orphan Drugs In Ue Countries

    Nov 1, 2015, 00:00

  • High-Dose Inactivated Influenza Vaccine can Reduce Costs and Improve Outcomes Compared to Standard-Dose Inactivated Influenza Vaccine in Canadian Seniors

    Nov 1, 2015, 00:00

  • Drug Pricing Reform in China - An Analysis of Piloted Pricing Approaches in the Context of International Experience

    Nov 1, 2015, 00:00

  • Full Economic Assessment of Rotavirus Vaccination Using the Health Economic Cauliflower Toolbox

    Nov 1, 2015, 00:00

  • Comparative Efficacy Of Treatments For Previously Treated Advanced Or Metastatic Non-Small Cell Lung Cancer (Nsclc)- A Network Meta-Analysis

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Vemurafenib Vs Ipilimumab Plus Dacarbacine in the Treatment of Non-Resectable Metastasic Melanoma with Braf600e Mutation in Colombia

    Nov 1, 2015, 00:00

  • Cost Savings By The Use Of Bemiparin In The Treatment Of Patients With Venous Thromboembolism In Spain

    Nov 1, 2015, 00:00

  • Regional Versus Centralized Hta- Implications for the Assessment of Cancer Drugs

    Nov 1, 2015, 00:00

  • Cost of Type 2 Diabetes According to Glucose-Lowering Medications in France

    Nov 1, 2015, 00:00

  • Aligning Patient Centred Evidence Generation Across the Drug Development Lifecycle

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Scotland

    Nov 1, 2015, 00:00

  • Basic Attitude Of Japanese Physicians Towards Healthcare Resource Allocation In A Setting Of Budget Constraints

    Nov 1, 2015, 00:00

  • Qualitative Assessment of Societal Preferences for Market Access of Cancer Drugs

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Obinutuzumab/Chlorambucil Vs Rituximab/Chlorambucil In Treatment Of Chronic Lymphocytic Leukemia

    Nov 1, 2015, 00:00

  • Dispensing of Vitamin Products by Retail Pharmacies in South Africa

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Tiotropium In The Treatment Of Patients With Asthma

    Nov 1, 2015, 00:00

  • Burden of Spinal Diseases- Results From Register Study In Sweden

    Nov 1, 2015, 00:00

  • Qualitative Equivalence Between Paper and Ediary Versions and Usability of 6 Pro Questionnaires for Endometriosis

    Nov 1, 2015, 00:00

  • Current Process and Future Path for Health Economic Assessment of Pharmaceuticals in France

    Nov 1, 2015, 00:00

  • Adjusting For Treatment Switching in Rcts – Identifying, Analysing and Justifying Appropriate Methods- a Case Study in Metastatic Melanoma

    Nov 1, 2015, 00:00

  • Quality of Life Among Hiv Patients- Results from the Ianua Clinical Trial

    Nov 1, 2015, 00:00

  • Data Mining Based On Real World Data In Chronic Kidney Disease Patients Not On Dialysis- The Key Role Of Early Hemoglobin Levels Control

    Nov 1, 2015, 00:00

  • The Rise of Orphan Drugs In Europe Vs The United States- Comparing Orphan Drug Designations Between The Ema And Fda

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Health State Utilities for Adults With Type 1 Diabetes

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Delayed-Release Dimethyl Fumerate For The Treatment of Relapsing-Remitting Multiple Sclerosis In Portugal

    Nov 1, 2015, 00:00

  • Children’s Medication In The Nordic Countries – Survey on National Administrative Register Data

    Nov 1, 2015, 00:00

  • The Association between Disease Activity and Quality of Life among Patients with Ankylosing Spondylitis in Polish Population

    Nov 1, 2015, 00:00

  • La Hipoglucemia Incrementa El Gasto En Salud Y Deteriora La Productividad De Pacientes Con Diabetes Tipo 1 Y Tipo 2

    Nov 1, 2015, 00:00

  • Descriptive Evalaution of Characteristics of Patients Diagnosed with Relapsing Remitting Multiple Sclerosis and Taking Disease Modifying Agents

    Nov 1, 2015, 00:00

  • Variation In State-Level Vs. National Incidence In Rare Genetic Disease- A Monte Carlo Simulation to Examine Sampling Variation As A Primary Explanation In Congenital Adrenal Hyperplasia

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of The Use of Daclatasvir for The Treatment of Hepatitis C Virus (Hcv) Genotypes 3, In The Italian Setting

    Nov 1, 2015, 00:00

  • Budget Impact Model for Cervical Cancer Screening Using Hpv Tests In Chile

    Nov 1, 2015, 00:00

  • Medication-Taking Behaviour in Women with Postmenopausal Osteoporosis (Op) Treated with Denosumab or Monthly Oral Bisphosphonates (Obps)

    Nov 1, 2015, 00:00

  • Achievement of Glycaemic Targets with Canagliflozin in Triple Therapy in Patients with Type 2 Diabetes Mellitus (T2DM)

    Nov 1, 2015, 00:00

  • Cost of Drug-Related Monitoring Requirements for Glatiramer Acetate and Other Multiple Sclerosis Disease-Modifying Therapies (Dmts)

    Nov 1, 2015, 00:00

  • Effectiveness Of Supporting Informal Caregivers Of People With Dementia- A Systematic Review

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Directly Mailed Fobt Kits To Previous Responders Being Recalled For Screening

    Nov 1, 2015, 00:00

  • Economic Burden of Type 2 Diabetes Mellitus For Mexico

    Nov 1, 2015, 00:00

  • Cost Saving Associated With Glucose Meter Accuraccy In Spain

    Nov 1, 2015, 00:00

  • Assessing The Esmo Magnitude of Clinical Benefit Scale From A Health Economics Perspective

    Nov 1, 2015, 00:00

  • Nub Status – An Analysis Comparing Results of 2015 Vs. 2014 - Leading Therapeutic Areas Confirmed

    Nov 1, 2015, 00:00

  • Survey on Romanian Hospitals Financing Reveals Major Dysfunctions In Covering Drug Treatment During Hospitalization

    Nov 1, 2015, 00:00

  • Developing Bilingual Certificate Programs in Clinical Pharmacy

    Nov 1, 2015, 00:00

  • The Medical Technologies Evaluation Programme (Mtep)- An Analysis Of Notifications, Decision-Making And The Interpretation Of Claimed Healthcare System Benefits

    Nov 1, 2015, 00:00

  • Treatment Patterns Among Front-Line Glioblastoma Patients In Five European Countries

    Nov 1, 2015, 00:00

  • Comparison of Direct Hospitalization Costs and Length of Stay In Carbapenem Resistant Versus Carbapenem Sensitive Klebsiella Pneumoniae Infections In A Tertiary Care Hospital

    Nov 1, 2015, 00:00

  • Outpatient Utilization and Quality Appraisal of Antibiotics in Turkey

    Nov 1, 2015, 00:00

  • Iron Deficiency In Patients With Chronic Heart Failure- A Systematic Literature Review

    Nov 1, 2015, 00:00

  • Network Meta-Analysis Of Multiple Outcomes Incorporating Dose-Related Constraints- Application To Overactive Bladder Syndrome

    Nov 1, 2015, 00:00

  • Economic Evaluation of Voriconazole in the Treatment of Invasive Aspergillosis

    Nov 1, 2015, 00:00

  • Influence of Patient-Reported Outcomes (Pro) on Market Access Decisions In Markets With Centralized Healthcare Systems

    Nov 1, 2015, 00:00

  • The Cost of Rehumatoid Diseases In Italy- Analysis From An Italian Administrative Database

    Nov 1, 2015, 00:00

  • Medical Costs And Resources Consumption In Patients With Atrial Fibrillation- An Italian Observational Study

    Nov 1, 2015, 00:00

  • Costs Analysis Of Pcr Unyverotm I60-Iti Technique For Detecting Microorganisms In Patients With Suspected Chronic Infection At Musculoskeletal Implants

    Nov 1, 2015, 00:00

  • Risk Of Pneumonia Associated With The Use Of Ics/Laba- A Retrospective Cohort Study In Korea

    Nov 1, 2015, 00:00

  • An Assessment of Annual Costs of Patients Hospitalized for Spinal Tumors in Fran Analysis Using the Pmsi Database

    Nov 1, 2015, 00:00

  • Cognitive Symptoms In Major Depressive Disorder And Their Italian Psychiatrists’ Perception

    Nov 1, 2015, 00:00

  • Relationship Between Adherence To Post Percutaneous Coronary Intervention (Pci) Guidelines And Clinical Outcomes Of Post-Pci Patients In Hong Kong - A 5-Year Retrospective Cohort Study

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Mirabegron Versus Antimuscarinic Treatments In Patients With Overactive Bladder From The Pespective Of The Spanish National Health Service

    Nov 1, 2015, 00:00

  • A Simulation Analysis Using The Orange Price Reference Tool

    Nov 1, 2015, 00:00

  • Using Decision Making Clinical Scenarios to Appraise Preferences and Value Judgments in Health Technology Assessment (Hta)

    Nov 1, 2015, 00:00

  • Relationship Between The Prevalence Of Cancers In England And Wales And The Performance Of Technology Appraisals

    Nov 1, 2015, 00:00

  • A Literature Review To Evaluate The Pharmacoeconomic Value Of Ranolazine For The Treatment Of Symptomatic Chronic Stable Angina

    Nov 1, 2015, 00:00

  • An Assessment of The Hospitalization Costs of Melanoma in France in the Advanced/Metastatic Setting- the Melissa Study (Melanoma in Hospital Costs Assessment)

    Nov 1, 2015, 00:00

  • Increase Arv Access for Plwha In Dominican Republic Through The Transition From Vertical Supply System to An Integrated National Pharmaceutical System

    Nov 1, 2015, 00:00

  • Anti-Dementia Medicine Dispensing Patterns- A Community Pharmacy Database Analysis

    Nov 1, 2015, 00:00

  • Resistência Antimicrobiana- Identificação Das Pesquisas Brasileiras Fomentadas Para Suporte À Gestão No País

    Nov 1, 2015, 00:00

  • Relationship of Time in Therapeutic Range (Ttr) with Bleeding and Stroke Incidences of Warfarinised Patients with Pulmonary Embolism in a Tertiary Hospital in Malaysia

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Continuous Remote Monitoring Of Heart Failure Patients With Cardiac Electronic Implantable Device

    Nov 1, 2015, 00:00

  • Assessment of Burden and Economic Impact of the Vandetanib Restricted Distribution Program in Canada

    Nov 1, 2015, 00:00

  • Study On Cost-Effectiveness Analysis For Multiple Myeloma Treatment- A Systematic Review Of Literature From 2004-2014

    Nov 1, 2015, 00:00

  • 5th LAC Abstracts FDS and 18th Euro Abstracts FDS - Financial Disclosure

    Nov 1, 2015, 00:00

  • Descriptive Epidemiology And Treatment Strategies Used In Multiply Myeloma In The Slovak Republic. Results From The Cross-Sectional Survey In The Haematology-Oncological Centers

    Nov 1, 2015, 00:00

  • A Microcosting Study Of Radiation Therapy In Localized Prostate Cancer Patients In A Hungarian Tertiary Oncology Center

    Nov 1, 2015, 00:00

  • Assessing The Potential for Tiered Pricing of High Priced Therapies Within Argentina, Columbia, Mexico, Indonesia, and Thailand

    Nov 1, 2015, 00:00

  • Convergent Validity of New Disease Assessment Instruments (Dai) In Systemic Lupus Erythematosus (Sle) In Relation to Sledai-2k

    Nov 1, 2015, 00:00

  • Progressive Disease Does Not Impact Hrqol In Patients Receiving Nivolumab For The Treatment Of Unresectable Or Metastatic Melanoma

    Nov 1, 2015, 00:00

  • Health Care Coverage Through Private Health Insurance

    Nov 1, 2015, 00:00

  • Comparative Effectiveness of Triple Antihypertensive Combination Therapy for Patients with Resistant Hypertension In Taiwan

    Nov 1, 2015, 00:00

  • Health-Economic Evaluation of Clostridium Difficile Infection (Cdi) And Epidemiology In England And Merseyside

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Intravitreal Aflibercept In Diabetic Macular Oedema In Sweden

    Nov 1, 2015, 00:00

  • Fluticasone Propionate Versus Budesonide or Beclomethasone As Monotherapy Treatment for Asthma Patients - A Systematic Review

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Transcatheter Aortic Valve Replacement- Current Decision-Analytic Models and Future Opportunities

    Nov 1, 2015, 00:00

  • Patient Perspective on Convenience and Intensification of Insulin Treatment In Type 2 Diabetes In Italy

    Nov 1, 2015, 00:00

  • Modelling The Likely Impact of The Obesity Epidemic on Mortality And Cause of Death In Older Adults

    Nov 1, 2015, 00:00

  • Assessment of Who/Inrud Core Drug Use Indicators in two Tertiary Care Hospitals of Bahawalpur, Punjab, Pakistan

    Nov 1, 2015, 00:00

  • Do Socioeconomic Inequalities Impact The Social Cost Of Chronic Kidney Disease In Italy?

    Nov 1, 2015, 00:00

  • Improved Survival In Patients With Advanced Melanoma In Real-World Clinical Practi First Results Of The Dutch Melanoma Treatment Registry

    Nov 1, 2015, 00:00

  • A Systematic Literature Review On The Impact Of Therapeutic Interventions On Quality Of Life In Systolic Hf Randomized Clinical Trials

    Nov 1, 2015, 00:00

  • A Review of Guidelines And Approaches to Performance-Based Risk-Sharing Agreements Across The Uk, Italy And The Netherlands

    Nov 1, 2015, 00:00

  • Adherence With Therapeutic Guidelines In The Treatment Of Venous Thromboembolism And Pulmonary Embolism In Clinical Practice. Findings From The Victor Study

    Nov 1, 2015, 00:00

  • Economic Evaluation Of Oral Anticoagulation Therapies (Oat) In China

    Nov 1, 2015, 00:00

  • Assessing the Translatability of the Term “Distressed”

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Treatments for Wet Age-Related Macular Degeneration (Wamd) In The Netherlands, The Case of Intravitreal Aflibercept (Ivt-Afl) and Ranibizumab

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Introducing Lisdexamfetamine Dimesylate for the Treatment of Binge Eating Disorder in the United States

    Nov 1, 2015, 00:00

  • Biopharma Intervention Valuation- An Evidence-Based Appraisal Framework for Oncology Drugs

    Nov 1, 2015, 00:00

  • La Canasta Basica de Medicamentos Como Estrategia Para Mejorar el Acceso y Costo de Los Medicamentos en Panama

    Nov 1, 2015, 00:00

  • Quality of Life in Patients After Total Hip Replacement

    Nov 1, 2015, 00:00

  • Impact Of A Novel Ibs Diagnostic Blood Panel For Mexico- Cost Implications To The Mexican Private Practice For Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Or 4 Chronic Hepatitis C in England and Wales

    Nov 1, 2015, 00:00

  • Current Challenges and Opportunities to Market Access in Brazil, Argentina, Mexico and Colombia

    Nov 1, 2015, 00:00

  • A Systematic Review of Model-Based Economic Evaluations of Drug Substitution Therapies in Maintenance Treatment of Non-Prescription Opioid Dependence

    Nov 1, 2015, 00:00

  • Economic Analysis Of Evarrest® Sealant Matrix Compared With Standard Of Care In Severe Soft Tissue Surgical Bleeding- An Italian Hospital Perspective

    Nov 1, 2015, 00:00

  • The Power of the Patient Voi Formalising Qualitative Data in the Drug Approval Process

    Nov 1, 2015, 00:00

  • The Indirect Costs of Types 1 Diabetes Mellitus Associated with Absenteeism in Poland in 2013

    Nov 1, 2015, 00:00

  • Using Tangent Line Segments to Determine Statistical Differences between Survival Curves at a Single Point in Time

    Nov 1, 2015, 00:00

  • Health-Economic Comparison of a Gnrh-Antagonist (Degarelix) Vs. Gnrh-Agonists Considering the Number-Needed-to-Treat to Avoid Cardiovascular Events

    Nov 1, 2015, 00:00

  • State and Prospects of Pharmacoeconomics Training in Ukraine

    Nov 1, 2015, 00:00

  • Patterns of Utilization and Cost of Prostacylins for Pulmonary Arterial Hypertension

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Moderate to Severe Psoriasis In Spain

    Nov 1, 2015, 00:00

  • Geographical Disparities in Colon Cancer Care in Europe- Implications for Access to Innovative Medicines Via the UK Cancer Drugs Fund

    Nov 1, 2015, 00:00

  • Inadequate Treatment of Post-Surgical Pain May Result in Extended Hospitalization Period

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Ferric Carboxymaltose in Patients with Colon Cancer and Anemia

    Nov 1, 2015, 00:00

  • Análisis de Costo Efectividad y Costo Utilidad de Rituximab Como Tratamiento en Pacientes Con Artritis Reumatoide, Ante el Fallo o Intolerancia en Primera Línea de un Anti-Tnf, en el Contexto Venezolano

    Nov 1, 2015, 00:00

  • The Burden of Moderate-To-Severe Irritable Bowel Syndrome With Constipation (Ibs-C) In Fran A Comparison With The European Results From The Ibis-C Observational Study

    Nov 1, 2015, 00:00

  • Humanistic Burden of Chronic Spontaneous Urticaria in Comparison to Psoriasis- European Perspective

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Insulin Analogues Compared with Multiple Daily Injections of Human Insulin for the Treatment of 15 Years Old or Older Patients with Type 1 Diabetes Mellitus in Colombia

    Nov 1, 2015, 00:00

  • How to Calculate Value of Information in Seconds Using ‘Savi’, the Sheffield Accelerated Value of Information Web App

    Nov 1, 2015, 00:00

  • Generalized Implementation of Em Algorithm for Estimation of Transition Probability Matrix

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis Of Apixaban In The Acute Treatment And Prevention Of Venous Thromboembolism In France

    Nov 1, 2015, 00:00

  • Network Meta-Analysis On Prevention Of Stroke For Patent Foramen Ovale Closure

    Nov 1, 2015, 00:00

  • Hurdles That Impede Economic Evaluations of Health Care Interventions Tested By General Practitioners In Flanders- A Qualitative Study

    Nov 1, 2015, 00:00

  • Contrasting Predictions of Cardiovascular Incidence Derived From Alternative Risk Prediction Models In Type 1 Diabetes

    Nov 1, 2015, 00:00

  • Budget Impact Analysis In The Uk Setting – Know Your Audience

    Nov 1, 2015, 00:00

  • Evaluation of Inpatients’satisfaction in Pafos General Hospital, Cyprus

    Nov 1, 2015, 00:00

  • The Association of Waist Circumference with Glycaemic Control in Diabetic Patients in an Asian Population

    Nov 1, 2015, 00:00

  • Simulating Individual Patient Level Data Using An Illness-Death Modelling Framework In Order to Adjust for Treatment Switching When Only Summary Data Are Available

    Nov 1, 2015, 00:00

  • The Economic Consequences of the use of Antidepressants in Belgium- Prescribing Behavior and Misuse of Antidepressants

    Nov 1, 2015, 00:00

  • Evaluation of The Effect of Crude Leaves Extract of Indigofera Spicata Forssk.(Fabaceae) on Blood Glucose Level of Normoglycemic, Oral Glucose Loaded and Alloxan Induced Diabetic Rodents

    Nov 1, 2015, 00:00

  • Scoping Review of Publicly Available Performance Information in Argentina, Chile and Colombia

    Nov 1, 2015, 00:00

  • Impact Of Her2 Testing Quality Improvement From A Health Economic Perspective

    Nov 1, 2015, 00:00

  • Inclusion Of A Novel Ibs Blood Panel For Diagnosing Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)- A Uk Perspective

    Nov 1, 2015, 00:00

  • Budget Impact Analysis Of Tripliam For The Treatment Of Hypertension In Italy

    Nov 1, 2015, 00:00

  • Benchmarking Health Technology Assessment (Hta) Agencies for Setting Standards on Pharmacoeconomic, Pricing, Evidence, and General Submission Requirements- development of a Multidimensional Rating Scale

    Nov 1, 2015, 00:00

  • Prescription Pattern of Outpatient Department of A Teaching Hospital Quetta, Pakistan

    Nov 1, 2015, 00:00

  • Selective Retina Therapy

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Blood Clotting Factor Concentrates In The Treatment of Von Willebrand Disease

    Nov 1, 2015, 00:00

  • Social Utility Values for Pemphigus Vulgaris and Foliaceus- A Composite Time Trade-Off Study

    Nov 1, 2015, 00:00

  • A One-Year Follow-Up of Individuals with Diabetes at Very High Cv Risk Treated With Statins- Outcomes and Health Care Costs

    Nov 1, 2015, 00:00

  • Economic Evaluation of Fecal Microbiota Transplantation for The Treatment of Recurrent Clostridium Difficile Infection In Australia

    Nov 1, 2015, 00:00

  • How Pricing And Reimbursement Policies Affect The Budget Impact of The Treatment of Systemic Juvenile Idiopathic Arthritis In Turkey

    Nov 1, 2015, 00:00

  • Does One Size Fit All? - Challenges Faced when Adapting Translations for an Electronic Platform

    Nov 1, 2015, 00:00

  • General Assessment Of Unlicensed Medicine Usage In Turkey

    Nov 1, 2015, 00:00

  • The Comparative Pharmacoeconomic Analysis Of Using Plerixafor For Stem Cell Mobilization For Autologous Peripheral Stem Cell Transplantation For Non-Hodgkin’s Lymphoma Patients

    Nov 1, 2015, 00:00

  • How to Determine The Target Population In Early Benefit Assessments In Germany? The Case of Diabetes Mellitus Type 2

    Nov 1, 2015, 00:00

  • Eficacia Y Seguridad Del Uso Del Cetuximab En Pacientes Con Cancer Colorrectal Metastásico

    Nov 1, 2015, 00:00

  • The Value of Achieving Complete or Near Complete Resolution of Psoriasis

    Nov 1, 2015, 00:00

  • Are Spanish Regions Implementing The National Therapeutic Positioning Report (Tpr) Regarding New Oral Anticoagulants (Noac) In The Same Way? A Case Of Regional Variability In Drug Access

    Nov 1, 2015, 00:00

  • The Trends In Orphan Drug Authorisation and Approval In Europe And In The United States - A Retrospective Study (2005-2014)

    Nov 1, 2015, 00:00

  • The Survey of Physicians’ Satisfaction of Implementing Interventions for Changing Prescribing Behavior Toward Rational Medicine Use-2014

    Nov 1, 2015, 00:00

  • Screening Guidelines And Cancer Stage- Early Findings From Medicare

    Nov 1, 2015, 00:00

  • An Analysis of German G-BA Added Benefit Assessment Decisions Using the World Health Organization Daly Framework

    Nov 1, 2015, 00:00

  • Biologics In Ulcerative Colitis (Uc)- Treatment Guidelines and Health Technology Assessments (Hta)

    Nov 1, 2015, 00:00

  • When “Alive After 5 Years” Does Not Mean “Cured”- International Patterns In Cancer 10- To 20- Year Relative Survival Rates

    Nov 1, 2015, 00:00

  • Quality Of Life In Women Patients With Urinary Incontinence In Slovakia

    Nov 1, 2015, 00:00

  • Potential Long-Term Cost Savings In Treatment of Naïve Hiv-Infected Patients With Rilpivirine/ Tenofovir/ Emtricitabine (Single Tablet Regimen) In The Russian Federation

    Nov 1, 2015, 00:00

  • Estimating The Economic Consequences Of An Increased Medication Compliance Due To A Potential Improvement Of The Inhaler Technique With Spiromax® Compared With Turbuhaler® In Moderate To Severe Patients With Copd In Spain

    Nov 1, 2015, 00:00

  • Re-Use Of Insulin Syringe Needles And Its Extra Disease Burden For Diabetic Patients In Beijing

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of The Combined Homocysteine-Lowering And Standard Therapy Versus Standard Therapy Of Patients With Chd, Postpercutaneous Coronary Intervention (Pci) And B12 Deficiency

    Nov 1, 2015, 00:00

  • Anemia Treatment Cost in Patients with Chronic Kidney Disease (A-Ckd) In The Mexican Social Security Institute (Imss)

    Nov 1, 2015, 00:00

  • Promis® Physical Function Multilingual Translations- Progress And Outlook

    Nov 1, 2015, 00:00

  • Hematological Toxicities Associated with Pazopanib use in Cancer Patients- A Meta-Analysis

    Nov 1, 2015, 00:00

  • Real-World Hepatitis C Treatment Strategies in Denmark

    Nov 1, 2015, 00:00

  • Economic Evaluation Of The Rotavirus Vaccination Among Children Under 5 Years Of Age In Switzerland

    Nov 1, 2015, 00:00

  • Students’ Knowledge and Perceptions Towards Quality Use of Medicines- A Descriptive Analysis From Universiti Sains Malaysia

    Nov 1, 2015, 00:00

  • Stimulant Use and Cardiovascular Risk Among Children And Adolescents With Adhd- What Product Labeling Does, or Does Not, Tell Us

    Nov 1, 2015, 00:00

  • The Budget Impact Analysis of Adjunctive Therapy for Patients With Partial Epilepsy

    Nov 1, 2015, 00:00

  • Hospitalization Costs of Type 2 Diabetes Mellitus (T2dm) Patients In A Public Hospital In Brazil

    Nov 1, 2015, 00:00

  • Costo Efectividad De La Hemodiálisis En Los Prestadores De Servicios De Dos Aseguradoras A Través De La Evaluación De Indicadores Mínimos Para El Análisis De Resultados Clínicos De La Terapia Dialítica En Colombia

    Nov 1, 2015, 00:00

  • Equity in Access to High Cost Drugs in Uruguay

    Nov 1, 2015, 00:00

  • Pilot Assessment Of Pharmaceuticals Based On The Eunethta Core Model For Rapid Relative Effectiveness Assessment

    Nov 1, 2015, 00:00

  • Therapeutic and Economic Value of Everolimus Plus Exemestane for the Treatment of Postmenopausal Women with Hormone Receptor-Positive, Her2/Neu Negative Advanced Breast Cancer

    Nov 1, 2015, 00:00

  • Clinical Characteristics and Patterns of Care Among Patients With Genotype 1 (G1) Hepatitis C Virus In Europe (Eu)

    Nov 1, 2015, 00:00

  • Cost-Savings And Cost-Utility Of An Ehr System Smartphone App In A Trauma Intensive Care Unit

    Nov 1, 2015, 00:00

  • Development of an Eq-5d Respiratory Bolt-on

    Nov 1, 2015, 00:00

  • Sipuleucel-T (Provenge®)- Autopsy of an Innovative Change of Paradigm in Cancer Treatment

    Nov 1, 2015, 00:00

  • The Economic Value Proposition of Hand-Sewn Suture Versus Stapled Anastomoses During Right Colon Surgery

    Nov 1, 2015, 00:00

  • Performance of Drg-Based Reimbursement Policy In National Health Insurance - Eight Years’ Experiences

    Nov 1, 2015, 00:00

  • Monitored Cognitive Debriefing Interviews- a Case Study

    Nov 1, 2015, 00:00

  • Valuation of Eq-5d Health States by Pharmacy Students in Poland (Comparison of Different Methods and with General Population)

    Nov 1, 2015, 00:00

  • Impact of Indiscriminate Use of Pump Infusion Set (Pis) on the Cost of Chemotherapy Treatments- A Cost Minimization Study

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Triple Therapy for Adults Patients with Genotype 1 Chronic Hepatitis C

    Nov 1, 2015, 00:00

  • Meta-Analysis of Mortality In Adults, Newborns and Older Children With Bacterial Infections And Sepsis When Treated By Igm-Enriched Intravenous Immunoglobulins And Standard Schemes

    Nov 1, 2015, 00:00

  • Effects Of Adverse Events On Quality Of Life Scores In A Randomized Clinical Trial Of Adjuvant Chemotherapy For Breast Cancer- N-Sas Bc 02

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ceritinib Versus Current Therapies for Chemotherapy-Experienced Anaplastic Lymphoma Kinase Positive Non-Small Cell Lung Cancer Patients in Mexico

    Nov 1, 2015, 00:00

  • Physicians’ Prescribing Pattern For Tuberculosis- Evidences From Community Pharmacies In Punjab, Pakistan

    Nov 1, 2015, 00:00

  • Clinical Responses and Improvements in Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2015, 00:00

  • Comparison Between The Interim Eq-5d-5l Score And The New Japanese Scoring In Stroke Patients

    Nov 1, 2015, 00:00

  • Costs Of Compression Therapy In Venous Leg Ulcers In Germany And Modelling Of The Economic Effects Of Regional Disparities In Health Care

    Nov 1, 2015, 00:00

  • Cost-effectiveness of Ranibizumab Vs. Dexamethasone Implant In Diabetic Macular Edema

    Nov 1, 2015, 00:00

  • Gender Differences in Medication Taking Behaviour- A Case of Osteoporosis

    Nov 1, 2015, 00:00

  • Impact Of Staging And Hormone Sensitivity On Quality Of Life In Us Prostate Cancer Patients

    Nov 1, 2015, 00:00

  • Patient Heterogeneity In Cost-Effectiveness Models for Chronic Obstructive Pulmonary Disease (Copd)- are Current Models Suitable to Evaluate Personalized Medicine

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Ponatinib In The Treatment of Chronic-Phase Chronic Myeloid Leukemia (Cp-Cml) In Sweden

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Apremilast In Patients With Psoriatic Arthritis In Spain

    Nov 1, 2015, 00:00

  • A Mixed Treatment Comparison (Mtc) to Compare the Efficacy of Anti-Thrombotic Agents in the Acute Treatment of Venous Thromboembolism (Vte) in Patients with Active Cancer

    Nov 1, 2015, 00:00

  • Access to Healthcare Among International Immigrants in Chile- Repeated Cross-Sectional Analysis of Casen Survey 2006-2009-2011

    Nov 1, 2015, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97 (current)
  • 98
  • 99
  • 100
  • »